Member Info for longshorttrade

Shame we will never know how many shorts were bought back today as i am not sure a low of 2.19p can be achieved again.

Vlad said the 28th Nov raise was a tide over to get us to FDA clearance, that clearance occurred nearly 3 weeks ago and the tide over raise was 3 months ago today.

Still not buying dilutive placement but i may be wrong and expect news any day now. there comes a point when shorters have to take profit most got in between 5p and 3.5p so not sure how much further they genuinely feel they can squeeze this.

It really wouldn't surprise me if a deal were to be announced around Funding , partnership or licensing on Friday, i genuinely can't see a placing as not sure he could get enough shares through as we require $10's of millions to move on and through clinical and presently that would represent anything between 4-800m shares to be issued, (it isn't going to happen. Hopefully Prevail and Vlad have been whittling down numerous offers for the one that best meets our needs.

This share is easy to short because to many in issue and low volume.

Wierdly in my isa at present i can buy or sell 100K for the same price 02.685

This really should be getting some serious press coverage this weekend in Mail on Sunday and sunday times, these are breathtaking announcements and should be picked up by mainstream press.

See details below i am not as sure as some of you arethat Prevail will be the investor here as not sure they have the cash and only have 5 investments one of which was our at circa $800,000 However they may introduce us as i suspect to the right third party to put in a significant investment.

Prevail Partners

This is a profile preview from the PitchBook Platform.

Request a free trial

Data on this profile

Overview

Investments

Investments Analytics

Team

Data Transparency

PitchBook also tracks

Exits

Fund Performance

Limited Partners

Lead Partners on Deals

Board Members

Co-investors

Service Providers

Prevail Partners Overview

Update this profile

Investor Type

Venture Capital

Status

Active

Professionals

2

Professionals

Investments

5

Portfolio

5

Prevail Partners General Information

Company Description

Founded in 2015, Prevail Partners is a venture capital firm based in Philadelphia, Pennsylvania. The firm seeks to invest in companies operating in the life sciences sector.

Business Details

Website

www.prevailpartners.com

Year Founded

2015

Investor Status

Actively Seeking New Investments

Primary Investor Type

Venture Capital

Corporate Office

211 North, 13th Street

6th Floor

Philadelphia, PA 19107

United States



Prevail Partners Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner

SOM Biotech 04-Dec-2023 Later Stage VC Drug Discovery Clinical Trials - Phase 2

Hemogenyx Pharmaceuticals 14-Sep-2023 Drug Discovery Generating Revenue

BriaCell Therapeutics 19-May-2023 Drug Discovery Profitable

PolyPhotonix 25-Jan-2022 Later Stage VC Biotechnology Generating Revenue

Nanocan Seed Round Biotechnology Pre-Clinical Trials To view Prevail Partners’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Sadly Pumpky that wouldn't be anywhere near enough to get us through trials and be able to continue on CBR and CDX Hence i believe licensing deal or JV.

There has to be virtually zero chance of a share placing at these prices with the 3 fantastic RNS we have received in one week. There has to be a JV or Licensing deal coming iimminently. This share price is a joke.

4p held this perfect , grow some boll--ks

Could we see some decent press coverage over the weekend to give it a further boost next week ?

IG will give me 3.88 for 1 mil

Thanks for your post RR, However i don't agree with your resumption date of 1.07.2024 for trading upon approvals, if we get approvals pre 2nd April we will be back up trading within days of admission doc submission in my opinion .

BC There are plenty of Traders about that will play the Divi trade, i can see it being announced as early as this week , with it going Ex Divi within a fortnight.

Yes that is indeed true as IG only reports on its clients and not the market as a whole.

I also found the increase in short positions on IG increase from 3 to 5% a little baffling this morning though it is insignificant in the grand scheme of things. Exciting times ahead.

Great RNS this morning and data submitted earlier than i anticipated, quick clear out of sellers and shorters and this will finish blue today and rise steadily until CH lifted. Thats my thoughts anyway. GLA

Thats what i am hoping Moorscloud

Correct Mickey, the whole process has to be reasonably quick and i mean weeks not months as the half million fund raise from end of November won't last much beyond that. Surely testing and data monitoring has been running in parallel with end to end run ?

RR doesn't that now put us in a very precarious catch 22 situation where debt providers won't engage without govt sources and SS govt who will be of the opinion who are you prove you have the funds ?

Found it now Thanks Charles

Can someone point me to where Vlad said we would be in clinical trials by end 2023, as i can't find it in any of the RNS's yet it has been mentioned many times on here.

RR: Has this come from your discussions with the Nomad or what you believe to be the case ?